Skip to main content

An MRI-based multi-objective radiomics model predicts lymph node status in patients with rectal cancer

Abstract

Purpose

To apply a multi-objective radiomics model based on pre-operative magnetic resonance imaging (MRI) for improving diagnostic accuracy of LN metastasis in rectal cancer patients.

Methods

This study consisted of 91 patients diagnosed with rectal cancer from April 2018 to March 2019. All patients underwent rectal MRI before surgery without any other treatment. Clinical data, subjective radiologist assessments, and radiomic features of LNs were obtained. A total of 1409 radiomic features were extracted from T2WI LN images. Multi-objective optimization with the iterative multi-objective immune algorithm (IMIA) was used to select radiomic features to build prediction models. Predictive performances of radiomic, radiologist, and combined radiomic and radiologist models were assessed for accuracy by receiver operating characteristics (ROC) curves.

Results

For the radiologist analysis, heterogeneity was the only significant independent predictor of LN status. The sensitivity, specificity, and accuracy of the subjective radiologist analysis were 72.09%, 73.81%, and 78.12%, respectively. The sensitivity, specificity, and accuracy of the solitary radiomic model consisting of 10 features were 89.81%, 82.57%, and 87.77%, respectively. The sensitivity, specificity, and accuracy of the combined model, which consisted of 12 radiomic and radiologist features, were 92.23%, 84.69%, and 89.88%, respectively. The combined model had the best prediction performance with an AUC of 0.94.

Conclusions

The multi-objective radiomics model based on T2WI images was very useful in predicting pre-operative LN status in rectal cancer patients.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Data availability

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Glynne-Jones R, Wyrwicz L, Tiret E, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018. 29(Suppl 4): iv263.

  2. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015. 136(5): E359-86.

    CAS  Article  Google Scholar 

  3. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016. 66(1): 7-30.

    Article  Google Scholar 

  4. Garland ML, Vather R, Bunkley N, Pearse M, Bissett IP. Clinical tumour size and nodal status predict pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer. Int J Colorectal Dis. 2014. 29(3): 301-7.

    Article  Google Scholar 

  5. Lutz MP, Zalcberg JR, Glynne-Jones R, et al. Second St. Gallen European Organisation for Research and Treatment of Cancer Gastrointestinal Cancer Conference: consensus recommendations on controversial issues in the primary treatment of rectal cancer. Eur J Cancer. 2016. 63: 11-24.

  6. Kokelaar RF, Evans MD, Davies M, Harris DA, Beynon J. Locally advanced rectal cancer: management challenges. Onco Targets Ther. 2016. 9: 6265-6272.

    CAS  Article  Google Scholar 

  7. Denost Q, Saillour F, Masya L, et al. Benchmarking trial between France and Australia comparing management of primary rectal cancer beyond TME and locally recurrent rectal cancer (PelviCare Trial): rationale and design. BMC Cancer. 2016. 16: 262.

    Article  Google Scholar 

  8. Abulafi AM, Williams NS. Local recurrence of colorectal cancer: the problem, mechanisms, management and adjuvant therapy. Br J Surg. 1994. 81(1): 7-19.

    CAS  Article  Google Scholar 

  9. Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007. 99(6): 433-41.

    Article  Google Scholar 

  10. Park JS, Jang YJ, Choi GS, et al. Accuracy of preoperative MRI in predicting pathology stage in rectal cancers: node-for-node matched histopathology validation of MRI features. Dis Colon Rectum. 2014. 57(1): 32-8.

    Article  Google Scholar 

  11. Kim JH, Beets GL, Kim MJ, Kessels AG, Beets-Tan RG. High-resolution MR imaging for nodal staging in rectal cancer: are there any criteria in addition to the size. Eur J Radiol. 2004. 52(1): 78-83.

    Article  Google Scholar 

  12. Bipat S, Glas AS, Slors FJ, Zwinderman AH, Bossuyt PM, Stoker J. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging–a meta-analysis. Radiology. 2004. 232(3): 773-83.

    Article  Google Scholar 

  13. Li XT, Sun YS, Tang L, Cao K, Zhang XY. Evaluating local lymph node metastasis with magnetic resonance imaging, endoluminal ultrasound and computed tomography in rectal cancer: a meta-analysis. Colorectal Dis. 2015. 17(6): O129-35.

    Article  Google Scholar 

  14. Bonifacio C, Viganò L, Felisaz P, et al. Diffusion-weighted imaging and loco-regional N staging of patients with colorectal liver metastases. Eur J Surg Oncol. 2019. 45(3): 347-352.

    Article  Google Scholar 

  15. Gröne J, Loch FN, Taupitz M, Schmidt C, Kreis ME. Accuracy of Various Lymph Node Staging Criteria in Rectal Cancer with Magnetic Resonance Imaging. J Gastrointest Surg. 2018. 22(1): 146-153.

    Article  Google Scholar 

  16. Chun YS, Pawlik TM, Vauthey JN. 8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers. Ann Surg Oncol. 2018. 25(4): 845-847.

    Article  Google Scholar 

  17. Heo SH, Kim JW, Shin SS, Jeong YY, Kang HK. Multimodal imaging evaluation in staging of rectal cancer. World J Gastroenterol. 2014. 20(15): 4244-55.

    Article  Google Scholar 

  18. Lambin P, Rios-Velazquez E, Leijenaar R, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012. 48(4): 441-6.

    Article  Google Scholar 

  19. Salvatore C, Castiglioni I, Cerasa A. Radiomics approach in the neurodegenerative brain. Aging Clin Exp Res. 2019.

  20. Gillies RJ, Kinahan PE, Hricak H. Radiomics: Images Are More than Pictures, They Are Data. Radiology. 2016. 278(2): 563-77.

    PubMed  Google Scholar 

  21. Pinker K, Chin J, Melsaether AN, Morris EA, Moy L. Precision Medicine and Radiogenomics in Breast Cancer: New Approaches toward Diagnosis and Treatment. Radiology. 2018. 287(3): 732-747.

    Article  Google Scholar 

  22. Ulrich EJ, Menda Y, Boles Ponto LL, et al. FLT PET Radiomics for Response Prediction to Chemoradiation Therapy in Head and Neck Squamous Cell Cancer. Tomography. 2019. 5(1): 161-169.

    Article  Google Scholar 

  23. Li Y, Eresen A, Lu Y, et al. Radiomics signature for the preoperative assessment of stage in advanced colon cancer. Am J Cancer Res. 2019. 9(7): 1429-1438.

    PubMed  PubMed Central  Google Scholar 

  24. Huang YQ, Liang CH, He L, et al. Development and Validation of a Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer. J Clin Oncol. 2016. 34(18): 2157-64.

    Article  Google Scholar 

  25. Liang C, Huang Y, He L, et al. The development and validation of a CT-based radiomics signature for the preoperative discrimination of stage I-II and stage III-IV colorectal cancer. Oncotarget. 2016. 7(21): 31401-12.

    Article  Google Scholar 

  26. Brown G, Richards CJ, Bourne MW, et al. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology. 2003. 227(2): 371-7.

    Article  Google Scholar 

  27. Zhou Z, Folkert M, Iyengar P, et al. Multi-objective radiomics model for predicting distant failure in lung SBRT. Phys Med Biol. 2017. 62(11): 4460-4478.

    Article  Google Scholar 

  28. McMahon CJ, Smith MP. Magnetic resonance imaging in locoregional staging of rectal adenocarcinoma. Semin Ultrasound CT MR. 2008. 29(6): 433-53.

    Article  Google Scholar 

  29. Beets-Tan R, Lambregts D, Maas M, et al. Correction to: Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol. 2018. 28(6): 2711.

    Article  Google Scholar 

  30. Cho EY, Kim SH, Yoon JH, et al. Apparent diffusion coefficient for discriminating metastatic from non-metastatic lymph nodes in primary rectal cancer. Eur J Radiol. 2013. 82(11): e662-8.

    Article  Google Scholar 

  31. Iannicelli E, Di Renzo S, Ferri M, et al. Accuracy of high-resolution MRI with lumen distention in rectal cancer staging and circumferential margin involvement prediction. Korean J Radiol. 2014. 15(1): 37-44.

    Article  Google Scholar 

  32. Chen LD, Liang JY, Wu H, Wang Z, Li SR, Li W, Zhang XH, Chen JH, Ye JN, Li X, Xie XY, Lu MD, Kuang M, Xu JB, Wang W (2018) Multiparametric radiomics improve prediction of lymph node metastasis of rectal cancer compared with conventional radiomics. Life Sci 208:55-63. https://doi.org/10.1016/j.lfs.2018.07.007

    CAS  Article  PubMed  Google Scholar 

  33. Tan X, Chen H, Zhang T, Wu H, Zeng Y, Huang F, Yu Y, Liu J, Liu P (2019) [Preoperative prediction for lymph node metastasis of rectal nonmucinous adenocarcinoma based on radiomics classifier]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 44:271-276. https://doi.org/10.11817/j.issn.1672-7347.2019.03.007

    Article  PubMed  Google Scholar 

  34. Song L, Yin J (2020) Application of Texture Analysis Based on Sagittal Fat-Suppression and Oblique Axial T2-Weighted Magnetic Resonance Imaging to Identify Lymph Node Invasion Status of Rectal Cancer. Front Oncol 10:1364. https://doi.org/10.3389/fonc.2020.01364

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This study has received funding by the Applied Technology Research, the Development Foundation of Harbin City (No. 2016RAQXJ043) and Harbin Medical University Cancer Hospital HaiYan Funds (No. JJZD2020-17).

Author information

Affiliations

Authors

Corresponding author

Correspondence to Kuan Luan.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Ethical approval

Ethical approval was obtained by the local institutional review board (Ethical Committee of Harbin Medical University Cancer Hospital).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Li, J., Zhou, Y., Wang, X. et al. An MRI-based multi-objective radiomics model predicts lymph node status in patients with rectal cancer. Abdom Radiol 46, 1816–1824 (2021). https://doi.org/10.1007/s00261-020-02863-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-020-02863-2

Keywords

  • Rectal cancer
  • Lymph nodes
  • Multi-objective radiomics
  • Magnetic resonance imaging